2019
DOI: 10.3389/fsufs.2019.00044
|View full text |Cite
|
Sign up to set email alerts
|

Bioprocess Design Considerations for Cultured Meat Production With a Focus on the Expansion Bioreactor

Abstract: Cultured meat, as a cellular agriculture product, utilizes tissue engineering techniques and consequently faces not only cell culture challenges but also scale-up limitations. To ensure cultured meat is financially viable, efficient bioprocess design for scale-up is required. In this mini-review we focus on the design of the expansion bioreactor, and put it in context of the entire bioprocess by providing an overview of the upstream and downstream process considerations. As a full-scale cultured meat bioproces… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
148
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 141 publications
(151 citation statements)
references
References 57 publications
0
148
0
3
Order By: Relevance
“…The bioreactor is a device to culture microcarrier‐attached cells or cell aggregates maintaining the optimized conditions through regulating the conditions of their in vitro environment, such as pH, temperature, gas, and metabolite or nutrition concentrations. Various factors including cell density, bioreactor volume, inoculation efficiency, media requirements, cleaning scaffold source, passaging, inoculation, and cell removal methods should be considered for the mass production of muscle stem cells using bioreactors (Allan, De Bank, & Ellis, 2019). Several studies have employed the bioreactors for an upscaled muscle stem cell production as described in Table 4.…”
Section: Upscaled Muscle Stem Cell Culturingmentioning
confidence: 99%
“…The bioreactor is a device to culture microcarrier‐attached cells or cell aggregates maintaining the optimized conditions through regulating the conditions of their in vitro environment, such as pH, temperature, gas, and metabolite or nutrition concentrations. Various factors including cell density, bioreactor volume, inoculation efficiency, media requirements, cleaning scaffold source, passaging, inoculation, and cell removal methods should be considered for the mass production of muscle stem cells using bioreactors (Allan, De Bank, & Ellis, 2019). Several studies have employed the bioreactors for an upscaled muscle stem cell production as described in Table 4.…”
Section: Upscaled Muscle Stem Cell Culturingmentioning
confidence: 99%
“…Scenario 1 represents a baseline scenario a based on existing ACBM production, including 2019 cost estimates for animal serumfree media and growth factors (12). Scenario 4 was designed as a bookend scenario, where nearly all technical challenges are resolved, including reduced growth factor costs, increased MSC/myoblast tolerance to glucose concentrations, decreased MSC/myoblast doubling and maturation time, and reduced basal media costs (6,12,14,17). Scenario 2 represents a mid-point scenario between Scenarios 1 and 4, and Scenario 3 adapts Scenario 2 by eliminating FGF-2 growth factor costs.…”
Section: Resultsmentioning
confidence: 99%
“…A number of technological hurdles to lower production cost have been identified but not extensively quantified (e.g. cell senescence, high cost of growth factors, time and nutrients required for cell growth/differentiation/ maturation, and scalable scaffolding processes) (14,17,18) Figure 1B illustrates a potential ACBM production system similar to monoclonal antibody production for bovine myoblasts/MSC expansion (6,19). We limit our analysis here to the core bioreactor system (section "C" in Figure 1B) since industrial-scale scaffolding and maturation systems have not been defined in detail by ACBM producers.…”
Section: Introductionmentioning
confidence: 99%
“…Ellis began her research career in regenerative medicine and has applied her bioprocess design techniques to the expansion of muscle cells for CM. Given her experience with in vitro liver models (Luetchford et al, 2018;Storm et al, 2016) and her earlycareer work on scaffold development for mesenchymal stem cell expansion (Morgan et al, 2007), she has positioned herself to develop platform technologies for a wide range of tissue engineered cellular agriculture products, specifically based around scalable bioreactor design (Allan et al, 2019). She has a research group, with funding from New Harvest amongst others, developing bioreactors and scaffolds for CM, and gives Chemical Engineering undergraduate students the opportunity to carry out major project work in this space, having now supervised over 30 Masters of Engineering student projects on the topic of cultured meat bioprocess design.…”
Section: University Laboratory Researchmentioning
confidence: 99%